AKTX Stock Analysis: Buy, Sell, or Hold?
AKTX - Akari Therapeutics plc ADR (0.01 USD)
$0.23
0.00 (-0.84%)
▼
5d:
-8.96%
30d:
-21.4%
90d:
-68.1%
HOLD
LOW Confidence
Analysis Updated: Feb 3, 2026 12:00 AM ET
Get Alerted When AKTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: AKTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: AKTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: AKTX is currently trading at $0.23, which is considered oversold relative to its 30-day fair value range of $0.25 to $0.29.
Technical Outlook: Technically, AKTX is in a strong downtrend. Immediate support is located at $0.22, while resistance sits at $0.28.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.53 (+1844.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AKTX is in a strong downtrend. Immediate support is located at $0.22, while resistance sits at $0.28.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.53 (+1844.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.25 -
$0.29
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1844.0% below Wall St target ($4.53)
- CAUTION: Recommendation downgraded due to -9.0% 5-day decline
Fair Price Analysis
30-Day Fair Range
$0.25 -
$0.29
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.22
Resistance Level
$0.28
Current Trend
Strong Downtrend
Technical data as of
Feb 4, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.58
Wall Street Target
$4.53
(+1844.0%)
Last updated: February 04, 2026 12:30 PM ET
Data refreshes hourly during market hours. Next update: 1:30 PM
Data refreshes hourly during market hours. Next update: 1:30 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AKTX showing a specific setup today?
Insider Activity (6 Months)
3
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Abizer Gaslightwala
BUY
3000 shares
2025-08-25
Abizer Gaslightwala
BUY
8000 shares
2025-08-22
Abizer Gaslightwala
BUY
10000 shares
2025-08-21
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$213 | 66 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 63 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$56 | 59 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 59 HOLD |
|
ARVN
Arvinas Inc |
BUY
21 analysts |
$13 | 58 HOLD |
